Page last updated: 2024-09-03

pentosidine and Chronic Progressive Multiple Sclerosis

pentosidine has been researched along with Chronic Progressive Multiple Sclerosis in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Benedict, RH; Bistulfi, GL; Chadha, K; Hennies, C; Kazim, L; Leung, C; Munschauer, F; Sternberg, D; Sternberg, Z; Weinstock-Guttman, B	1

Other Studies

1 other study(ies) available for pentosidine and Chronic Progressive Multiple Sclerosis

Article	Year
Plasma pentosidine: a potential biomarker in the management of multiple sclerosis. Multiple sclerosis (Houndmills, Basingstoke, England), 2011, Volume: 17, Issue:2 Topics: Adult; Analysis of Variance; Arginine; Biomarkers; Case-Control Studies; Chromatography, High Pressure Liquid; Cross-Sectional Studies; Disability Evaluation; Female; Humans; Inflammation Mediators; Linear Models; Lysine; Male; Middle Aged; Multiple Sclerosis, Chronic Progressive; Multiple Sclerosis, Relapsing-Remitting; New York; Predictive Value of Tests; Recurrence; Severity of Illness Index; Spectrometry, Fluorescence; Time Factors; Treatment Outcome; Up-Regulation	2011

Article

Year

Plasma pentosidine: a potential biomarker in the management of multiple sclerosis.

Multiple sclerosis (Houndmills, Basingstoke, England), 2011, Volume: 17, Issue:2

Topics: Adult; Analysis of Variance; Arginine; Biomarkers; Case-Control Studies; Chromatography, High Pressure Liquid; Cross-Sectional Studies; Disability Evaluation; Female; Humans; Inflammation Mediators; Linear Models; Lysine; Male; Middle Aged; Multiple Sclerosis, Chronic Progressive; Multiple Sclerosis, Relapsing-Remitting; New York; Predictive Value of Tests; Recurrence; Severity of Illness Index; Spectrometry, Fluorescence; Time Factors; Treatment Outcome; Up-Regulation

2011